What is the proper procedure for infusing intravenous (IV) artesunate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Artesunate Infusion Procedure

IV artesunate should be administered at a dose of 2.4 mg/kg at 0,12, and 24 hours, then daily, until parasitemia is <1% and the patient can take oral medication. 1

Preparation and Administration

  1. Reconstitution:

    • Artesunate powder should be reconstituted in 5% dextrose solution
    • Ensure complete dissolution before administration
  2. Dosing Schedule:

    • First dose: 2.4 mg/kg at hour 0
    • Second dose: 2.4 mg/kg at hour 12
    • Third dose: 2.4 mg/kg at hour 24
    • Subsequent doses: 2.4 mg/kg once daily
  3. Administration Method:

    • Administer as a slow IV bolus injection
    • Alternative: IV infusion over 2-4 hours (for improved stability)

Stability Considerations

Artesunate has limited stability at room temperature, which is a critical consideration when preparing the medication:

  • At 23°C (room temperature): Stable for approximately 10.6 hours 2
  • At 30°C (tropical conditions): Stable for approximately 4 hours 2
  • At 36.5°C (body temperature): Stable for only 1.6 hours 2

Therefore, freshly prepare the solution shortly before administration and do not store reconstituted solution for extended periods.

Monitoring During Treatment

  • Check parasitemia every 12 hours until <1%, then every 24 hours until negative 1
  • Monitor complete blood count, liver function, kidney function, and metabolic parameters daily 1
  • Watch for post-artesunate delayed hemolysis (PADH), a known complication 3
  • Monitor glucose levels regularly as hypoglycemia can occur 1

Duration of IV Treatment

Continue IV artesunate until:

  1. Parasitemia is <1% AND
  2. Patient can tolerate oral medication

Then switch to a complete course of oral antimalarial therapy (artemether-lumefantrine, dihydroartemisinin-piperaquine, or atovaquone-proguanil) 1.

Special Considerations

  • Artesunate is preferred over quinine for severe malaria due to:

    • More rapid parasite clearance
    • Lower mortality (15% vs 22%) 4
    • Better safety profile with fewer side effects 4
    • Simpler administration 4
  • If IV artesunate is unavailable, IV quinine is the alternative (loading dose 20 mg salt/kg over 4 hours, then 10 mg salt/kg every 8 hours) 1

  • Artesunate can be safely administered with hydroxyurea in patients with conditions such as sickle cell disease 1

The rapid action of artesunate makes it the drug of choice for severe malaria, with its ability to quickly reduce parasite load and improve clinical outcomes compared to traditional treatments like quinine.

References

Guideline

Malaria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.